193 related articles for article (PubMed ID: 1632851)
1. Familial defective apolipoprotein B100: clinical characteristics of 54 cases.
Rauh G; Keller C; Kormann B; Spengel F; Schuster H; Wolfram G; Zöllner N
Atherosclerosis; 1992 Feb; 92(2-3):233-41. PubMed ID: 1632851
[TBL] [Abstract][Full Text] [Related]
2. Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia.
Rauh G; Keller C; Schuster H; Wolfram G; Zöllner N
Clin Investig; 1992 Jan; 70(1):77-84. PubMed ID: 1600334
[TBL] [Abstract][Full Text] [Related]
3. Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.
Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
Klin Wochenschr; 1991 May; 69(7):320-4. PubMed ID: 2067318
[TBL] [Abstract][Full Text] [Related]
4. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Pimstone SN; Defesche JC; Clee SM; Bakker HD; Hayden MR; Kastelein JJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
[TBL] [Abstract][Full Text] [Related]
5. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
Myant NB
Atherosclerosis; 1993 Dec; 104(1-2):1-18. PubMed ID: 8141833
[TBL] [Abstract][Full Text] [Related]
6. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
Miserez AR; Keller U
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
[TBL] [Abstract][Full Text] [Related]
7. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
[TBL] [Abstract][Full Text] [Related]
8. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
9. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
[TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
11. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
12. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
Ceska R; Vrablík M; Horínek A
Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) in subjects with familial defective apolipoprotein B100.
Perombelon YF; Gallagher JJ; Myant NB; Soutar AK; Knight BL
Atherosclerosis; 1992 Feb; 92(2-3):203-12. PubMed ID: 1385954
[TBL] [Abstract][Full Text] [Related]
15. Familial defective apolipoprotein B-100: haplotype analysis of the arginine(3500)----glutamine mutation.
Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
Atherosclerosis; 1991 Jun; 88(2-3):219-26. PubMed ID: 1892487
[TBL] [Abstract][Full Text] [Related]
16. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
17. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
[TBL] [Abstract][Full Text] [Related]
18. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
Morash B; Guernsey DL; Tan MH; Dempsey G; Nassar BA
Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics.
Kotze MJ; Peeters AV; Langenhoven E; Wauters JG; Van Gaal LF
Atherosclerosis; 1994 Dec; 111(2):217-25. PubMed ID: 7718024
[TBL] [Abstract][Full Text] [Related]
20. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
